Insights from 2023 ESGO Annual Meeting
A

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comparing Weekly Dose-Dense Chemo + Bev to 3-Weekly Chemo + Bev in 1L HR Stage 3-4 Epithelial Ovarian Cancer - Primary PFS Analysis"

By Insights from 2023 ESGO Annual Meeting FEATURING Andrew Clamp
By Insights from 2023 ESGO Annual Meeting FEATURING Andrew Clamp
250 views
October 11, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
06:50
Fengting Yan

Year in Review: Ovarian Cancer

11:15
Total Health

2024 Updates in Ovarian Cancer

Feat. T. Tillmanns
25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
28:11
OncoAlert

Ovarian Cancer: Setting a New Standard of Care

Feat. M. Raza Mirza
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
11:37
UCLA Health

Recurrent Cervical Cancer Updates

Feat. R. Salani
17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux
11:02
SGO 2023 Conference Coverage on VuMedi

Chemoradiation for Stage IB3 Cervical Cancer

Feat. J. Mayadev
08:19
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT…

Feat. M. Raza Mirza
24:12
Jubilee Brown

Rare Ovarian Cancer: Epithelial Tumors

28:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

The Role of Immunotherapy and Targeted Therapy in GYN Cancers

Feat. S. Gaillard
05:55
Integrity Continuing Education

Expert Panel Case Discussion: BRCA+ Epithelial Ovarian Cancer Who Ha…

Feat. M. Murphy, E. Teplinsky, M. Finkel
16:52
2023 Evolution Conference

PARP Inhibitors in GYN Cancers

Feat. T. Berman
18:13
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "CA125 Kinetics - KELIM to Help Select Ovar…

Feat. B. You
09:40
Kristina Butler

Update Report: The Latest in Advanced Cervical Cancer

13:04
Nebraska Oncology Society

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Feat. M. Clark
26:18
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Ovarian Cancer Treatment Updates

Feat. K. Banda